Literature DB >> 2871313

Captopril, enalapril, and blood glucose.

J McMurray, D M Fraser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2871313     DOI： 10.1016/s0140-6736(86)91304-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.

Authors:  Fleur Grégoire; Antoine Pariente; Annie Fourrier-Reglat; Françoise Haramburu; Bernard Bégaud; Nicholas Moore
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

Review 3.  ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?

Authors:  C C Kelleher
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

4.  Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans.

Authors:  Kerstin M Oltmanns; Eva Deininger; Peter Wellhoener; Bernd Schultes; Werner Kern; Esther Marx; Peter Dominiak; Jan Born; Horst L Fehm; Achim Peters
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

Review 5.  Perindopril safety and tolerance in at-risk patients.

Authors:  S Brichard; A E Lambert
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 6.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 7.  Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.

Authors:  R Donnelly; A D Morris
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

8.  ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.

Authors:  E Torlone; A M Rambotti; G Perriello; G Botta; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

Review 9.  The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.

Authors:  Elena Bernobich; Luisa de Angelis; Carlos Lerin; Giuseppe Bellini
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 10.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.